Cite Filings / RLAY / 0001193125-26-186929
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
DEF 14A

Proxy Statement

Relay Therapeutics, Inc. · Filed 2026-04-28 · Acc 0001193125-26-186929

Documents 1

  • DEF 14A Proxy Statement , rlay-20260424.htm

Around this filing

  • 2026-04-30 4 Rahmer Peter sold 753 shares at $14.79 ($11,137)
  • 2026-04-30 4 President, R&D sold 1,490 shares at $14.79 ($22,037)
  • 2026-04-28 ARS Annual Report to Security Holders
  • 2026-04-28 DEFA14A Proxy Materials
  • 2026-04-28 DEF 14A Proxy Statement
  • 2026-04-27 8-K Regulation FD disclosure · Other events
  • 2025-04-23 DEF 14A Proxy Statement

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading rlay-20260424.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…